Related Experiment Video
Updated: Aug 11, 2026

Quantitative Comparison of cis-Regulatory Element (CRE) Activities in Transgenic Drosophila melanogaster
Published on: December 19, 2011
Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of
1Center for Ligand and Transcription, Department of Biology, Chonnam National University, Kwangju 500-757, Korea.
Abstract:
ASC-2 is a recently isolated transcriptional cointegrator molecule, which is amplified in human cancers and stimulates transactivation by nuclear receptors, AP-1, nuclear factor kappaB (NFkappaB), serum response factor (SRF), and numerous other transcription factors. ASC-2 contained two nuclear receptor-interaction domains, both of which are dependent on the integrity of their core LXXLL sequences. Surprisingly, the C-terminal LXXLL motif specifically interacted with oxysterol receptor LXRss, whereas the N-terminal motif bound a broad range of nuclear receptors. These interactions appeared to be essential because a specific subregion of ASC-2 including the N- or C-terminal LXXLL motif acted as a potent dominant negative mutant with transactivation by appropriate nuclear receptors. In addition, the autonomous transactivation domain (AD) of ASC-2 was found to consist of three separable subregions; i.e. AD1, AD2, and AD3. In particular, AD2 and AD3 were binding sites for CREB binding protein (CBP), and CBP-neutralizing E1A repressed the autonomous transactivation function of ASC-2. Furthermore, the receptor transactivation was not enhanced by ASC-2 in the presence of E1A and significantly impaired by overexpressed AD2. From these results, we concluded that ASC-2 directly binds to nuclear receptors and recruits CBP to mediate the nuclear receptor transactivation in vivo.
Insights
ASC-2, a cancer-amplified transcriptional coactivator, binds nuclear receptors and recruits CBP. This interaction is crucial for nuclear receptor-mediated transactivation, highlighting ASC-2
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- ASC-2 is a transcriptional coactivator amplified in human cancers.
- It enhances transcription by various factors including nuclear receptors, AP-1, and NFkappaB.
- ASC-2 possesses two nuclear receptor-interaction domains with critical LXXLL motifs.
Purpose of the Study:
- To elucidate the mechanism by which ASC-2 interacts with nuclear receptors and mediates transactivation.
- To identify the specific domains and interactions involved in ASC-2's function.
- To investigate the role of CBP in ASC-2-mediated nuclear receptor activity.
Main Methods:
- Analysis of ASC-2's nuclear receptor-binding domains (LXXLL motifs).
- Construction and testing of dominant negative mutants of ASC-2.
- Identification and characterization of the autonomous transactivation domain (AD) of ASC-2.
- Investigating the interaction of ASC-2 with CBP and the effect of E1A.
Main Results:
- ASC-2 contains two LXXLL motifs, with the C-terminal motif binding LXR and the N-terminal binding multiple nuclear receptors.
- Subregions of ASC-2 containing these motifs function as dominant negative mutants.
- The autonomous transactivation domain (AD) of ASC-2 comprises AD1, AD2, and AD3, with AD2 and AD3 binding CBP.
- CBP-neutralizing E1A and overexpressed AD2 inhibit ASC-2's transactivation function.
Conclusions:
- ASC-2 directly binds nuclear receptors through its LXXLL motifs.
- ASC-2 recruits CBP via its AD2 and AD3 domains to mediate nuclear receptor transactivation.
- These findings clarify the molecular mechanism of ASC-2 in regulating gene expression.
More Related Videos
10:51Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 16, 2013
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
Co-activators and Co-repressors
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...